| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 2 Department of Epidemiology, Harvard School of Public Health; 3 Harvard Center for Cancer Prevention, Boston, Massachusetts; and 4 Cancer Genetics and Epidemiology Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia
Requests for reprints: Rulla M. Tamimi, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-525-0862. E-mail: rulla.tamimi{at}channing.harvard.edu.
Background: Mammographic density is one of the strongest predictors of breast cancer risk. The mechanism by which breast density increases breast cancer risk is unclear although it has been hypothesized that breast density reflects cumulative exposure to estrogens.
Methods: To evaluate this hypothesis, we conducted a cross-sectional study among 520 postmenopausal women in the Nurses' Health Study that examined the relation between circulating sex hormones and mammographic density. Women were postmenopausal and not taking exogenous hormones at the time of blood collection and mammogram. Percent breast density was measured from digitized mammograms using a computer-assisted method. Circulating estrone, estradiol, androstenedione, testosterone, DHEA, DHEA sulfate, sex hormone–binding globulin, progesterone, and prolactin were measured in plasma.
Results: In contrast to the prior hypothesis, circulating estrogens were inversely related to percent mammographic density. The mean percent mammographic density was 25.6% among women in the lowest quartile of circulating estradiol compared with 14.4% among women in the highest quartile [Spearman correlation (r) = –0.22, P < 0.0001]. Circulating estrogens alone explained 1% to 5% of the variation of mammographic density. Body mass index was positively associated with circulating estradiol levels (r = 0.45, P < 0.0001) and inversely related to percent mammographic density (r = –0.51, P < 0.0001). After adjustment for body mass index, there was no association between estradiol and breast density (r = 0.01, P = 0.81). Likewise, there was no relation between the other sex hormones measured or prolactin and mammographic density after adjustment for body mass index.
Conclusion: These findings indicate that in postmenopausal women, mammographic density is independent of circulating sex hormone levels.
This article has been cited by other articles:
|
|
 |
|
  M. B. Terry, D. S.M. Buist, A. Trentham-Dietz, T. M. James-Todd, and Y. Liao Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1088 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ghosh, K. R. Brandt, T. A. Sellers, C. Reynolds, C. G. Scott, S. D. Maloney, M. J. Carston, V. S. Pankratz, and C. M. Vachon Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 872 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Peters, U. Ekelund, M. Leitzmann, D. Easton, R. Warren, R. Luben, S. Bingham, K.-T. Khaw, and N. J. Wareham Physical Activity and Mammographic Breast Density in the EPIC-Norfolk Cohort Study Am. J. Epidemiol., March 1, 2008; 167(5): 579 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nagata, T. Matsubara, T. Hara, H. Fujita, Y. Nagao, S. Yamamoto, C. Shibuya, Y. Kashiki, and H. Shimizu Urinary 6-Sulfatoxymelatonin and Mammographic Density in Japanese Women Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2509 - 2512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sellers, C. Vachon, V. Pankratz, C. Janney, Z Fredericksen, K. Brandt, Y Huang, F. Couch, L. Kushi, and J. Cerhan Association of Childhood and Adolescent Anthropometric Factors, Physical Activity, and Diet with Adult Mammographic Breast Density Am. J. Epidemiol., August 15, 2007; 166(4): 456 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Tamimi, C. Byrne, G. A. Colditz, and S. E. Hankinson Endogenous Hormone Levels, Mammographic Density, and Subsequent Risk of Breast Cancer in Postmenopausal Women J Natl Cancer Inst, August 1, 2007; 99(15): 1178 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Vachon, V. S. Pankratz, C. G. Scott, S. D. Maloney, K. Ghosh, K. R. Brandt, T. Milanese, M. J. Carston, and T. A. Sellers Longitudinal Trends in Mammographic Percent Density and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 921 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Boyd, L. J. Martin, L. Sun, H. Guo, A. Chiarelli, G. Hislop, M. Yaffe, and S. Minkin Body Size, Mammographic Density, and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2086 - 2092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Warren, J. Skinner, E. Sala, E. Denton, M. Dowsett, E. Folkerd, C. S. Healey, A. Dunning, D. Doody, B. Ponder, et al. Associations among Mammographic Density, Circulating Sex Hormones, and Polymorphisms in Sex Hormone Metabolism Genes in Postmenopausal Women. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1502 - 1508. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
